Ilaris 150 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26FFBV8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,286
Award facts
- Contract value 100% obligated
- $29,286.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $29,286.02 to DMS Pharmaceutical Group Inc. for ILARIS 150 mg/ml vials on January 9, 2026, with an ultimate completion date of February 2, 2026. This firm fixed-price delivery order was awarded without a set-aside designation, allowing the woman-owned small business pharmaceutical wholesaler to compete directly against other qualified vendors. DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, will perform work at its Park Ridge location and will deliver the specified pharmaceutical product to support Department of Defense medical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy awarded on November 13, 2025. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous prior delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FFBV8?
SPE2DR26FFBV8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FFBV8 worth?
The government has obligated $29,286 on SPE2DR26FFBV8.
Is contract SPE2DR26FFBV8 an order under another contract?
Yes. SPE2DR26FFBV8 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBV8 competed?
The extent of competition for SPE2DR26FFBV8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award